AstraZeneca

COVID-19 Vaccine Expected by This Year End: AstraZeneca CEO

The vaccine was administered in a woman, who experienced neurological symptoms which is a rare but serious spinal inflammatory disorder called transverse myelitis, CEO Pascal Soriot, AstraZeneca said.